The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The Natural Course of Infantile Pompe’s Disease: 20 Original Cases Compared With 133 Cases From the Literature
Open accessAbstract
Objective. Infantile Pompe’s disease is a lethal cardiac and muscular disorder. Current developments toward enzyme replacement therapy are promising. The aim of our study is to delineate the natural course of the disease to verify endpoints of clinical studies. Methods. A total of 20 infantile patients diagnosed by the collaborative Dutch centers and 133 cases reported in literature were included in the study. Information on clinical history, physical examination, and diagnostic parameters was collected. Results. The course of Pompe’s disease is essentially the same in the Dutch and the general patient population. Symptoms start at a median age of 1.6 months in both groups. The median age of death is 7.7 and 6 months, respectively. Five percent of the Dutch patients and 8% of all reported patients survive beyond 1 year of age. Only 2 patients from literature became older than 18 months. A progressive cardiac hypertrophy is characteristic for infantile Pompe’s disease. The diastolic thickness of the left ventricular posterior wall and cardiac weight at autopsy increase significantly with age. Motor development is severely delayed and major developmental milestones are generally not achieved. For the Dutch patient group, growth deviates significantly from normal despite start of nasogastric tube feeding. Levels of aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, creatine kinase, or creatine kinase-myocardial band isoenzyme are typically elevated, although aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase increase significantly with age. The patients have fully deleterious mutations. Acid α-glucosidase activity is severely deficient. Conclusions. Survival, decrease of the diastolic thickness of the left ventricular posterior wall, and achievement of major motor milestones are valid endpoints for therapeutic studies of infantile Pompe’s disease. Mutation analysis and measurement of the α-glucosidase activity should be part of the enrollment program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease)
HERS, H. (1963) · Biochemical Journal · doi:10.1042/bj0860011 · Cited by 870
Critical review of the literature
HORVÁTH, I. (1984) · Modelling in the Technology of Wastewater Treatment · doi:10.1016/b978-0-08-023978-1.50007-x · Cited by 531
Amalfitano, A., Bengur, A. R., Morse, R. P., Majure, J. M., Case, L. E., Veerling, D. L., Mackey, J., Kishnani, P., Smith, W., McVie-Wylie, A., et al. (2001) · Genetics in Medicine · doi:10.1038/gim200127 · Cited by 347
HERS, H. G. (1964) · Advances in Metabolic Disorders · doi:10.1016/b978-1-4831-6748-0.50006-9 · Cited by 343
Recombinant human α-glucosidase from rabbit milk in Pompe patients
Van den Hout, H., Reuser, A. J., Vulto, A. G., Christa B Loonen, M., Cromme-Dijkhuis, A., & Van der Ploeg, A. T. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02533-2 · Cited by 330
Self-citationAusems, M., Verbiest, J., Hermans, M., Kroos, M., Beemer, F., Wokke, J., Sandkuijl, L., Reuser, A., & van der Ploeg, A. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200367 · Cited by 307
Self-citationOver idiopathische hypertrophie van het hart
Pompe, J. (1932) · Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank · Cited by 290
The spectrum and diagnosis of acid maltase deficiency
Engel, A. G., Gomez, M. R., Seybold, M. E., & Lambert, E. H. (1973) · Neurology · doi:10.1212/wnl.23.1.95 · Cited by 255
Martiniuk, F., Chen, A., Mack, A., Arvanitopoulos, E., Chen, Y., Rom, W. N., Codd, W. J., Hanna, B., Alcabes, P., Raben, N., et al. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980827)79:1<69::aid-ajmg16>3.0.co;2-k · Cited by 220
Enzyme therapy for Pompe disease with recombinant human α‐glucosidase from rabbit milk
Van den Hout, J. M. P., Reuser, A. J. J., de Klerk, J. B. C., Arts, W. F., Smeitink, J. A. M., & Van der Ploeg, A. T. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1010383421286 · Cited by 172
Self-citationIdentification of two subtypes of infantile acid maltase deficiency
Slonim, A. E., Bulone, L., Ritz, S., Goldberg, T., Chen, A., & Martiniuk, F. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.107112 · Cited by 165
Bijvoet, A. G. A., Hirtum, H. V., Kroos, M. A., van de Kamp, E. H. M., Schoneveld, O., de Visser, P. J., Brakenhoff, J. P. J., Weggeman, M., van Corven, E. J., van der Ploeg, A. T., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2145 · Cited by 125
Self-citationReuser, A. J. J., Kroos, M. A., Elferink, R. P. J. O., & Tager, J. M. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39477-2 · Cited by 112
Self-citationAmalfitano, A., Bengur, A. R., Morse, R. P., Majure, J. M., Case, L. E., Veerling, D. L., Mackey, J. F., Kishnani, P. S., Smith, W. E., McVie-Wylie, A. J., et al. (2001) · Genetics in Medicine · doi:10.1097/00125817-200103000-00008 · Cited by 91
POMPEʼS DISEASE (DIFFUSE GLYCOGENOSIS) WITH NEURONAL STORAGE* † ‡
Mancall, E. L., Aponte, G. E., & Berry, R. G. (1965) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196501000-00008 · Cited by 83
Genotype‐phenotype correlation in adult‐onset acid maltase deficiency
Wokke, J. H. J., Ausems, M. G. E. M., van den Boogaard, M. H., Ippel, E. F., van Diggelen, O., Kroos, M. A., Boer, M., Jennekens, F. G. I., Reuser, A. J. J., & van Amstel, H. K. P. (1995) · Annals of Neurology · doi:10.1002/ana.410380316 · Cited by 82
Self-citationPompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome
Bulkley, B. H., & Hutchins, G. M. (1978) · American Heart Journal · doi:10.1016/0002-8703(78)90093-5 · Cited by 81
Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene
Poorkaj, P., Sharma, V., Anderson, L., Nemens, E. J., Alonso, M. E., Orr, H. T., White, J. A., Heston, L. L., Bird, T. D., & Schellenberg, G. D. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)11:3<209::aid-humu5>3.0.co;2-c · Cited by 61
Glycogen disease resembling mongolism, cretinism, and amytonia congenita
Clement, D. H., & Godman, G. C. (1950) · The Journal of Pediatrics · doi:10.1016/s0022-3476(50)80174-9 · Cited by 57
Genetic defects in patients with glycogenosis type II (acid maltase deficiency)
Raben, N., Nichols, R. C., Boerkoel, C. F., & Plötz, P. H. (1995) · Muscle & Nerve · doi:10.1002/mus.880181415 · Cited by 50
Hogan, G. R., Gutmann, L., Schmidt, R., & Gilbert, E. F. (1969) · Neurology · doi:10.1212/wnl.19.9.894 · Cited by 48
Seifert, B. L., Snyder, M. S., Klein, A. A., OʼLoughlin, J. E., Magid, M. S., & Engle, M. A. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90779-u · Cited by 34
Infantile Pompe's disease, lipid storage, and partial carnitine deficiency
Verity, M. A. (1991) · Muscle & Nerve · doi:10.1002/mus.880140509 · Cited by 32
2Disorders of glycogen metabolism
Mahler, R. F. (1976) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(76)80041-2 · Cited by 23
Glycogen storage disease of the heart
Friedman, S., & Ash, R. (1958) · The Journal of Pediatrics · doi:10.1016/s0022-3476(58)80262-0 · Cited by 18
Lipid Storage Myopathy in Infantile Pompe's Disease
Sarnat, H. B., Roth, S. I., Carroll, J. E., Brown, B., & Dungan, W. T. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510150050012 · Cited by 15
Ausems, M. G. E. M., Kroos, M. A., der Kraan, M. V., Smeitink, J. A. M., Kleijer, W. J., van Amstel, H. K. P., & Reuser, A. J. J. (1996) · Clinical Genetics · doi:10.1111/j.1399-0004.1996.tb03801.x · Cited by 13
Self-citation[Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease].
Willemsen, M., Jira, P. E., Gabreëls, F. J. M., van der Ploeg, A. T., & Smeitink, J. A. M. (1998) · PubMed · Cited by 13
Self-citationThe endocrine glands in Pompe's disease. Report of two cases.
Hui, K. K. S., Williams, J. C., Borit, A., & Rosenberg, H. S. (1985) · PubMed · Cited by 12
Glycogen Storage Disease, Type II
Sethuraman, S., Mahamood, M., Krishnanunni, S., & Rajalakshmi (2006) · Humana Press eBooks · doi:10.1007/978-1-60327-161-5_87 · Cited by 2
Cited by
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e230 · Cited by 818
Recombinant human acid α-glucosidase: Major clinical benefits in infantile-onset Pompe disease
Kishnani, P. S., Corzo, D., Nicolino, M., Byrne, B., Mandel, H., Hwu, W. L., Leslie, N., Levine, J., Spencer, C., McDonald, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000251268.41188.04 · Cited by 781
Self-citation
Metadata
- Authors
- van den Hout, H. M. P., Hop, W., van Diggelen, O. P., Smeitink, J. A. M., Smit, G. P. A., Poll-The, B.-T. T., Bakker, H. D., Loonen, M. C. B., de Klerk, J. B. C., Reuser, A. J. J., & van der Ploeg, A. T.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2003-08-01
- Volume
- 112
- Issue
- 2
- Pages
- 332-340
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2144392873
- Cited by
- 555
- References
- 32
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.